Home > > > > Report Detail

Global Kinase Inhibitors Market Growth 2020-2025

Publisher Name :
Date: 15-Dec-2020
No. of pages: 135

According to this study, over the next five years the Kinase Inhibitors market will register a 4.6%% CAGR in terms of revenue, the global market size will reach $ 61030 million by 2025, from $ 51000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Kinase Inhibitors business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Kinase Inhibitors market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Kinase Inhibitors, covering the supply chain analysis, impact assessment to the Kinase Inhibitors market size growth rate in several scenarios, and the measures to be undertaken by Kinase Inhibitors companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Tyrosin kinase inhibitors (TKI)

- Receptor Tyrosine Kinase Inhibitors

- Non-Receptor Tyrosine Kinase Inhibitors

- Mulikinase inhibitors

- Threonine kinase inhibitor

- Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Pharmaceutical companies

- Private and Government research institutes

- Academic Institutes

- Healthcare facilities

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Bristol-Myers Squibb

- Pfizer

- Boehringer Ingelheim

- Eisai Inc.

- Eton Bioscience Inc.

- Cytrx Corporation

- Novartis International Ag

- Glaxosmithkline

- Osi Pharmaceuticals Llc

- Merck Serono Sa

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Kinase Inhibitors consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Kinase Inhibitors market by identifying its various subsegments.

- Focuses on the key global Kinase Inhibitors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Kinase Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Kinase Inhibitors submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Kinase Inhibitors Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Kinase Inhibitors Consumption 2015-2025
2.1.2 Kinase Inhibitors Consumption CAGR by Region
2.2 Kinase Inhibitors Segment by Type
2.2.1 Tyrosin kinase inhibitors (TKI)
2.2.2 Receptor Tyrosine Kinase Inhibitors
2.2.3 Non-Receptor Tyrosine Kinase Inhibitors
2.2.4 Mulikinase inhibitors
2.2.5 Threonine kinase inhibitor
2.2.6 Others
2.3 Kinase Inhibitors Consumption by Type
2.3.1 Global Kinase Inhibitors Consumption Market Share by Type (2015-2020)
2.3.2 Global Kinase Inhibitors Revenue and Market Share by Type (2015-2020)
2.3.3 Global Kinase Inhibitors Sale Price by Type (2015-2020)
2.4 Kinase Inhibitors Segment by Application
2.4.1 Pharmaceutical companies
2.4.2 Private and Government research institutes
2.4.3 Academic Institutes
2.4.4 Healthcare facilities
2.5 Kinase Inhibitors Consumption by Application
2.5.1 Global Kinase Inhibitors Consumption Market Share by Type (2015-2020)
2.5.2 Global Kinase Inhibitors Value and Market Share by Type (2015-2020)
2.5.3 Global Kinase Inhibitors Sale Price by Type (2015-2020)

3 Global Kinase Inhibitors by Company
3.1 Global Kinase Inhibitors Sales Market Share by Company
3.1.1 Global Kinase Inhibitors Sales by Company (2018-2020)
3.1.2 Global Kinase Inhibitors Sales Market Share by Company (2018-2020)
3.2 Global Kinase Inhibitors Revenue Market Share by Company
3.2.1 Global Kinase Inhibitors Revenue by Company (2018-2020)
3.2.2 Global Kinase Inhibitors Revenue Market Share by Company (2018-2020)
3.3 Global Kinase Inhibitors Sale Price by Company
3.4 Global Kinase Inhibitors Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Kinase Inhibitors Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Kinase Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Kinase Inhibitors by Regions
4.1 Kinase Inhibitors by Regions
4.2 Americas Kinase Inhibitors Consumption Growth
4.3 APAC Kinase Inhibitors Consumption Growth
4.4 Europe Kinase Inhibitors Consumption Growth
4.5 Middle East & Africa Kinase Inhibitors Consumption Growth

5 Americas
5.1 Americas Kinase Inhibitors Consumption by Countries
5.1.1 Americas Kinase Inhibitors Consumption by Countries (2015-2020)
5.1.2 Americas Kinase Inhibitors Value by Countries (2015-2020)
5.2 Americas Kinase Inhibitors Consumption by Type
5.3 Americas Kinase Inhibitors Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Kinase Inhibitors Consumption by Regions
6.1.1 APAC Kinase Inhibitors Consumption by Regions (2015-2020)
6.1.2 APAC Kinase Inhibitors Value by Regions (2015-2020)
6.2 APAC Kinase Inhibitors Consumption by Type
6.3 APAC Kinase Inhibitors Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Kinase Inhibitors by Countries
7.1.1 Europe Kinase Inhibitors Consumption by Countries (2015-2020)
7.1.2 Europe Kinase Inhibitors Value by Countries (2015-2020)
7.2 Europe Kinase Inhibitors Consumption by Type
7.3 Europe Kinase Inhibitors Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Kinase Inhibitors by Countries
8.1.1 Middle East & Africa Kinase Inhibitors Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Kinase Inhibitors Value by Countries (2015-2020)
8.2 Middle East & Africa Kinase Inhibitors Consumption by Type
8.3 Middle East & Africa Kinase Inhibitors Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Kinase Inhibitors Distributors
10.3 Kinase Inhibitors Customer

11 Global Kinase Inhibitors Market Forecast
11.1 Global Kinase Inhibitors Consumption Forecast (2021-2025)
11.2 Global Kinase Inhibitors Forecast by Regions
11.2.1 Global Kinase Inhibitors Forecast by Regions (2021-2025)
11.2.2 Global Kinase Inhibitors Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Regions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Kinase Inhibitors Forecast by Type
11.8 Global Kinase Inhibitors Forecast by Application

12 Key Players Analysis
12.1 Bristol-Myers Squibb
12.1.1 Company Information
12.1.2 Kinase Inhibitors Product Offered
12.1.3 Bristol-Myers Squibb Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bristol-Myers Squibb Latest Developments
12.2 Pfizer
12.2.1 Company Information
12.2.2 Kinase Inhibitors Product Offered
12.2.3 Pfizer Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer Latest Developments
12.3 Boehringer Ingelheim
12.3.1 Company Information
12.3.2 Kinase Inhibitors Product Offered
12.3.3 Boehringer Ingelheim Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boehringer Ingelheim Latest Developments
12.4 Eisai Inc.
12.4.1 Company Information
12.4.2 Kinase Inhibitors Product Offered
12.4.3 Eisai Inc. Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Eisai Inc. Latest Developments
12.5 Eton Bioscience Inc.
12.5.1 Company Information
12.5.2 Kinase Inhibitors Product Offered
12.5.3 Eton Bioscience Inc. Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Eton Bioscience Inc. Latest Developments
12.6 Cytrx Corporation
12.6.1 Company Information
12.6.2 Kinase Inhibitors Product Offered
12.6.3 Cytrx Corporation Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Cytrx Corporation Latest Developments
12.7 Novartis International Ag
12.7.1 Company Information
12.7.2 Kinase Inhibitors Product Offered
12.7.3 Novartis International Ag Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Novartis International Ag Latest Developments
12.8 Glaxosmithkline
12.8.1 Company Information
12.8.2 Kinase Inhibitors Product Offered
12.8.3 Glaxosmithkline Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Glaxosmithkline Latest Developments
12.9 Osi Pharmaceuticals Llc
12.9.1 Company Information
12.9.2 Kinase Inhibitors Product Offered
12.9.3 Osi Pharmaceuticals Llc Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Osi Pharmaceuticals Llc Latest Developments
12.10 Merck Serono Sa
12.10.1 Company Information
12.10.2 Kinase Inhibitors Product Offered
12.10.3 Merck Serono Sa Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Merck Serono Sa Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Kinase Inhibitors Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tyrosin kinase inhibitors (TKI)
Table 5. Major Players of Receptor Tyrosine Kinase Inhibitors
Table 6. Major Players of Non-Receptor Tyrosine Kinase Inhibitors
Table 7. Major Players of Mulikinase inhibitors
Table 8. Major Players of Threonine kinase inhibitor
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Kinase Inhibitors Consumption Market Share by Type (2015-2020)
Table 12. Global Kinase Inhibitors Revenue by Type (2015-2020) ($ million)
Table 13. Global Kinase Inhibitors Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Kinase Inhibitors Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Kinase Inhibitors Consumption Market Share by Application (2015-2020)
Table 17. Global Kinase Inhibitors Value by Application (2015-2020)
Table 18. Global Kinase Inhibitors Value Market Share by Application (2015-2020)
Table 19. Global Kinase Inhibitors Sale Price by Application (2015-2020)
Table 20. Global Kinase Inhibitors Sales by Company (2017-2019) (K Units)
Table 21. Global Kinase Inhibitors Sales Market Share by Company (2017-2019)
Table 22. Global Kinase Inhibitors Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Kinase Inhibitors Revenue Market Share by Company (2017-2019)
Table 24. Global Kinase Inhibitors Sale Price by Company (2017-2019)
Table 25. Global Kinase Inhibitors Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Kinase Inhibitors Products Offered
Table 27. Kinase Inhibitors Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Kinase Inhibitors Consumption by Regions 2015-2020 (K Units)
Table 29. Global Kinase Inhibitors Consumption Market Share by Regions 2015-2020
Table 30. Global Kinase Inhibitors Value by Regions 2015-2020 ($ Millions)
Table 31. Global Kinase Inhibitors Value Market Share by Regions 2015-2020
Table 32. Americas Kinase Inhibitors Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Kinase Inhibitors Consumption Market Share by Countries (2015-2020)
Table 34. Americas Kinase Inhibitors Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Kinase Inhibitors Value Market Share by Countries (2015-2020)
Table 36. Americas Kinase Inhibitors Consumption by Type (2015-2020) (K Units)
Table 37. Americas Kinase Inhibitors Consumption Market Share by Type (2015-2020)
Table 38. Americas Kinase Inhibitors Consumption by Application (2015-2020) (K Units)
Table 39. Americas Kinase Inhibitors Consumption Market Share by Application (2015-2020)
Table 40. APAC Kinase Inhibitors Consumption by Regions (2015-2020) (K Units)
Table 41. APAC Kinase Inhibitors Consumption Market Share by Regions (2015-2020)
Table 42. APAC Kinase Inhibitors Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Kinase Inhibitors Value Market Share by Regions (2015-2020)
Table 44. APAC Kinase Inhibitors Consumption by Type (2015-2020) (K Units)
Table 45. APAC Kinase Inhibitors Consumption Market Share by Type (2015-2020)
Table 46. APAC Kinase Inhibitors Consumption by Application (2015-2020) (K Units)
Table 47. APAC Kinase Inhibitors Consumption Market Share by Application (2015-2020)
Table 48. Europe Kinase Inhibitors Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Kinase Inhibitors Consumption Market Share by Countries (2015-2020)
Table 50. Europe Kinase Inhibitors Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Kinase Inhibitors Value Market Share by Countries (2015-2020)
Table 52. Europe Kinase Inhibitors Consumption by Type (2015-2020) (K Units)
Table 53. Europe Kinase Inhibitors Consumption Market Share by Type (2015-2020)
Table 54. Europe Kinase Inhibitors Consumption by Application (2015-2020) (K Units)
Table 55. Europe Kinase Inhibitors Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Kinase Inhibitors Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Kinase Inhibitors Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Kinase Inhibitors Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Kinase Inhibitors Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Kinase Inhibitors Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Kinase Inhibitors Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Kinase Inhibitors Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Kinase Inhibitors Consumption Market Share by Application (2015-2020)
Table 64. Kinase Inhibitors Distributors List
Table 65. Kinase Inhibitors Customer List
Table 66. Global Kinase Inhibitors Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Kinase Inhibitors Consumption Market Forecast by Regions
Table 68. Global Kinase Inhibitors Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Kinase Inhibitors Value Market Share Forecast by Regions
Table 70. Global Kinase Inhibitors Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Kinase Inhibitors Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Kinase Inhibitors Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Kinase Inhibitors Value Market Share Forecast by Type (2021-2025)
Table 74. Global Kinase Inhibitors Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Kinase Inhibitors Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Kinase Inhibitors Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Kinase Inhibitors Value Market Share Forecast by Application (2021-2025)
Table 78. Bristol-Myers Squibb Product Offered
Table 79. Bristol-Myers Squibb Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 80. Bristol-Myers Squibb Main Business
Table 81. Bristol-Myers Squibb Latest Developments
Table 82. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Product Offered
Table 84. Pfizer Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Pfizer Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer Ingelheim Product Offered
Table 89. Boehringer Ingelheim Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. Eisai Inc. Product Offered
Table 94. Eisai Inc. Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 95. Eisai Inc. Main Business
Table 96. Eisai Inc. Latest Developments
Table 97. Eisai Inc. Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 98. Eton Bioscience Inc. Product Offered
Table 99. Eton Bioscience Inc. Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 100. Eton Bioscience Inc. Main Business
Table 101. Eton Bioscience Inc. Latest Developments
Table 102. Eton Bioscience Inc. Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 103. Cytrx Corporation Product Offered
Table 104. Cytrx Corporation Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 105. Cytrx Corporation Main Business
Table 106. Cytrx Corporation Latest Developments
Table 107. Cytrx Corporation Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis International Ag Product Offered
Table 109. Novartis International Ag Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis International Ag Main Business
Table 111. Novartis International Ag Latest Developments
Table 112. Novartis International Ag Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 113. Glaxosmithkline Product Offered
Table 114. Glaxosmithkline Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 115. Glaxosmithkline Main Business
Table 116. Glaxosmithkline Latest Developments
Table 117. Glaxosmithkline Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 118. Osi Pharmaceuticals Llc Product Offered
Table 119. Osi Pharmaceuticals Llc Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 120. Osi Pharmaceuticals Llc Main Business
Table 121. Osi Pharmaceuticals Llc Latest Developments
Table 122. Osi Pharmaceuticals Llc Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 123. Merck Serono Sa Product Offered
Table 124. Merck Serono Sa Kinase Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 125. Merck Serono Sa Main Business
Table 126. Merck Serono Sa Latest Developments
Table 127. Merck Serono Sa Basic Information, Company Total Revenue (in $ million), Kinase Inhibitors Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Kinase Inhibitors
Figure 2. Kinase Inhibitors Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Kinase Inhibitors Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Kinase Inhibitors Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tyrosin kinase inhibitors (TKI)
Figure 7. Product Picture of Receptor Tyrosine Kinase Inhibitors
Figure 8. Product Picture of Non-Receptor Tyrosine Kinase Inhibitors
Figure 9. Product Picture of Mulikinase inhibitors
Figure 10. Product Picture of Threonine kinase inhibitor
Figure 11. Product Picture of Others
Figure 12. Global Kinase Inhibitors Consumption Market Share by Type (2015-2020)
Figure 13. Global Kinase Inhibitors Value Market Share by Type (2015-2020)
Figure 14. Kinase Inhibitors Consumed in Pharmaceutical companies
Figure 15. Global Kinase Inhibitors Market: Pharmaceutical companies (2015-2020) (K Units)
Figure 16. Global Kinase Inhibitors Market: Pharmaceutical companies (2015-2020) ($ Millions)
Figure 17. Kinase Inhibitors Consumed in Private and Government research institutes
Figure 18. Global Kinase Inhibitors Market: Private and Government research institutes (2015-2020) (K Units)
Figure 19. Global Kinase Inhibitors Market: Private and Government research institutes (2015-2020) ($ Millions)
Figure 20. Kinase Inhibitors Consumed in Academic Institutes
Figure 21. Global Kinase Inhibitors Market: Academic Institutes (2015-2020) (K Units)
Figure 22. Global Kinase Inhibitors Market: Academic Institutes (2015-2020) ($ Millions)
Figure 23. Kinase Inhibitors Consumed in Healthcare facilities
Figure 24. Global Kinase Inhibitors Market: Healthcare facilities (2015-2020) (K Units)
Figure 25. Global Kinase Inhibitors Market: Healthcare facilities (2015-2020) ($ Millions)
Figure 26. Global Kinase Inhibitors Consumption Market Share by Application (2015-2020)
Figure 27. Global Kinase Inhibitors Value Market Share by Application (2015-2020)
Figure 28. Global Kinase Inhibitors Sales Market Share by Company in 2017
Figure 29. Global Kinase Inhibitors Sales Market Share by Company in 2019
Figure 30. Global Kinase Inhibitors Revenue Market Share by Company in 2017
Figure 31. Global Kinase Inhibitors Revenue Market Share by Company in 2019
Figure 32. Global Kinase Inhibitors Sale Price by Company in 2019
Figure 33. Global Kinase Inhibitors Consumption Market Share by Regions 2015-2020
Figure 34. Global Kinase Inhibitors Value Market Share by Regions 2015-2020
Figure 35. Americas Kinase Inhibitors Consumption 2015-2020 (K Units)
Figure 36. Americas Kinase Inhibitors Value 2015-2020 ($ Millions)
Figure 37. APAC Kinase Inhibitors Consumption 2015-2020 (K Units)
Figure 38. APAC Kinase Inhibitors Value 2015-2020 ($ Millions)
Figure 39. Europe Kinase Inhibitors Consumption 2015-2020 (K Units)
Figure 40. Europe Kinase Inhibitors Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Kinase Inhibitors Consumption 2015-2020 (K Units)
Figure 42. Middle East & Africa Kinase Inhibitors Value 2015-2020 ($ Millions)
Figure 43. Americas Kinase Inhibitors Consumption Market Share by Countries in 2019
Figure 44. Americas Kinase Inhibitors Value Market Share by Countries in 2019
Figure 45. Americas Kinase Inhibitors Consumption Market Share by Type in 2019
Figure 46. Americas Kinase Inhibitors Consumption Market Share by Application in 2019
Figure 47. United States Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 48. United States Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 50. Canada Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 52. Mexico Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Kinase Inhibitors Consumption Market Share by Countries in 2019
Figure 54. APAC Kinase Inhibitors Value Market Share by Regions in 2019
Figure 55. APAC Kinase Inhibitors Consumption Market Share by Type in 2019
Figure 56. APAC Kinase Inhibitors Consumption Market Share by Application in 2019
Figure 57. China Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 58. China Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 60. Japan Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 62. Korea Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 64. Southeast Asia Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 65. India Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 66. India Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 68. Australia Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Kinase Inhibitors Consumption Market Share by Countries in 2019
Figure 70. Europe Kinase Inhibitors Value Market Share by Countries in 2019
Figure 71. Europe Kinase Inhibitors Consumption Market Share by Type in 2019
Figure 72. Europe Kinase Inhibitors Consumption Market Share by Application in 2019
Figure 73. Germany Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 74. Germany Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 75. France Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 76. France Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 77. UK Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 78. UK Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 80. Italy Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 82. Russia Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa Kinase Inhibitors Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa Kinase Inhibitors Value Market Share by Countries in 2019
Figure 85. Middle East & Africa Kinase Inhibitors Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa Kinase Inhibitors Consumption Market Share by Application in 2019
Figure 87. Egypt Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 88. Egypt Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 90. South Africa Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 91. Israel Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 92. Israel Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 94. Turkey Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries Kinase Inhibitors Consumption Growth 2015-2020 (K Units)
Figure 96. GCC Countries Kinase Inhibitors Value Growth 2015-2020 ($ Millions)
Figure 97. Global Kinase Inhibitors Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 98. Global Kinase Inhibitors Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 100. Americas Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 101. APAC Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 102. APAC Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 103. Europe Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 104. Europe Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 106. Middle East & Africa Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 107. United States Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 108. United States Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 109. Canada Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 110. Canada Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 111. Mexico Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 112. Mexico Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 113. Brazil Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 114. Brazil Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 115. China Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 116. China Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 117. Japan Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 118. Japan Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 119. Korea Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 120. Korea Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 122. Southeast Asia Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 123. India Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 124. India Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 125. Australia Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 126. Australia Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 127. Germany Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 128. Germany Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 129. France Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 130. France Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 131. UK Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 132. UK Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 133. Italy Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 134. Italy Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 135. Russia Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 136. Russia Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 137. Spain Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 138. Spain Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 139. Egypt Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 140. Egypt Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 141. South Africa Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 142. South Africa Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 143. Israel Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 144. Israel Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 145. Turkey Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 146. Turkey Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 147. GCC Countries Kinase Inhibitors Consumption 2021-2025 (K Units)
Figure 148. GCC Countries Kinase Inhibitors Value 2021-2025 ($ Millions)
Figure 149. Bristol-Myers Squibb Kinase Inhibitors Market Share (2018-2020)
Figure 150. Pfizer Kinase Inhibitors Market Share (2018-2020)
Figure 151. Boehringer Ingelheim Kinase Inhibitors Market Share (2018-2020)
Figure 152. Eisai Inc. Kinase Inhibitors Market Share (2018-2020)
Figure 153. Eton Bioscience Inc. Kinase Inhibitors Market Share (2018-2020)
Figure 154. Cytrx Corporation Kinase Inhibitors Market Share (2018-2020)
Figure 155. Novartis International Ag Kinase Inhibitors Market Share (2018-2020)
Figure 156. Glaxosmithkline Kinase Inhibitors Market Share (2018-2020)
Figure 157. Osi Pharmaceuticals Llc Kinase Inhibitors Market Share (2018-2020)
Figure 158. Merck Serono Sa Kinase Inhibitors Market Share (2018-2020)
  • Global Erythrocyte Catalase Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Erythrocyte Catalase market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Erythrocyte Catalase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Erythrocyte Catalase is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Endoenzyme Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Endoenzyme market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The application scenarios of endozymes are very wide and can be used in many fields such as chemical reagents, medical treatment, and environmental protection. With The continuous development of science and technology, The application scenarios of endozymes will continue to expand. This will further promote......
  • Global CASP9 Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    CASP9 (Caspase 9) is a Protein Coding gene. Diseases associated with CASP9 include Cerebral Hypoxia and Colorectal Cancer. Among its related pathways are TNFR1 Pathway and Apoptosis and survival FAS signaling cascades. Gene Ontology (GO) annotations related to this gene include protein kinase binding and peptidase activity. An important paralog of this gene is CASP2. The global CASP9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing......
  • Global Collagenase Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Collagenase, obtained from Clostridium histolyticum, is an enzyme used for tissue dissociation in vitro and thus for isolation of many different types of cells. These isolated cells are then used for numerous clinical and research applications. The global Collagenase market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 92 million by 2030, witnessing a CAGR of 2.2% during The forecast period 2024-2030. The global collagenase market is mainly compos......
  • Global Industrial Enzymes Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 123
    Enzymes are protein molecules functioning as specialized catalysts for chemical reactions. They have contributed greatly to The traditional and modern chemical industry by improving existing processes. Enzymes are natural catalysts. They are produced by living organisms to increase The rate of an immense and diverse set of chemical reactions required for life. They are involved in all processes essential for life such as DNA replication and transcription, protein synthesis, metabolism and signal......
  • Global Phytases Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Phytases market size was valued at US$ 490.1 million in 2023. With growing demand in downstream market, the Phytases is forecast to a readjusted size of US$ 732.7 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Phytases market. Phytases are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Trypsin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Trypsin market size was valued at US$ 214.3 million in 2023. With growing demand in downstream market, the Trypsin is forecast to a readjusted size of US$ 374.5 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Trypsin market. Trypsin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Cellulase Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Cellulase market size was valued at US$ 1980 million in 2023. With growing demand in downstream market, the Cellulase is forecast to a readjusted size of US$ 3084 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Cellulase market. Cellulase are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Restriction Endonucleases Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Restriction Endonucleases market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Restriction Endonucleases is forecast to a readjusted size of US$ 397 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Restriction Endonucleases market. Restriction Endonucleases are expected to show stable growth in the future m......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs